Federal Liaisons
The Role of the Federal Liaison in the NHSN
Federal Liaisons are scientists or program officers who:
- Are affiliated with the NIH or another relevant public health service agency;
- Have expertise in drug abuse research, or in a closely related area; and
- Have expertise in research with Hispanic populations (applies only to relevant disciplines).
Federal Liaisons are not NHSN members; rather, they provide critical knowledge and guidance to our national network of research scientist and graduate student members. Some of the activities that Federal Liaisons have engaged in include delivering presentations and workshops at the NHSN annual national scientific conference; teaching graduate students and postdoctoral fellows at the Interdisciplinary Research Training Institute on Hispanic Drug Abuse; and serving as ad hoc members of the Conference Planning Subcommittee and/or other working subcommittees.
Federal Liaisons
 |
Ana Anders, L.I.C.S.W. Senior Advisor on Special Populations Office of Special Populations National Institute on Drug Abuse aanders@nida.nih.gov |
 |
Judith Arroyo, Ph.D. Health Sciences Administrator National Institute on Alcohol Abuse & Alcoholism jarroyo@mail.nih.gov |
 |
Wilson M. Compton, M.D., M.P.E. Director Division of Epidemiology, Services & Prevention Research National Institute on Drug Abuse wc88f@nih.gov |
|
Jean Lud Cadet, M.D. Chief, Molecular Neuropsychiatry Branch National Institute on Drug Abuse jcadet@intra.nida.nih.gov |
|
Marta De Santis, Ph.D. Regulatory Specialist Pharmocotherapies and Medial Consequences National Institute on Drug Abuse mdesantis@nida.nih.gov |
|
Pebbles Fagan, Ph.D., M.P.H. Health Scientist Tobacco Control Research Branch Behavioral Research Program National Cancer Institute faganp@mail.nih.gov |
|
Joseph Fracella, Ph.D. Director Division of Clinical Neurosciences & Behavioural Treatment National Institute on Drug Abuse jfrascel@nida.nih.gov |
 |
Steve Gust, Ph.D. Director NIDA International Program Office of Science Policy & Communications National Institute on Drug Abuse ipdirector@nida.nih.gov |
 |
Alfonso R. Latoni, Ph.D. Deputy Chief, Scientific Review Branch National Institute on Aging National Institutes of Health alfonso.latoni@nih.gov |
|
Raúl Mandler, M.D. Senior Medical Officer Center for Clinical Trials Network National Institute on Drug Abuse mandlerr@mail.nih.gov |
 |
Iván Montoya, M.D., M.P.H. Medical Officer Division of Treatment Research & Development National Institute on Drug Abuse imontoya@mail.nih.gov |
|
Jacques Normand, Ph.D. Director AIDS Research Program National Institute on Drug Abuse jnormand@nida.nih.gov |
|
Carmen Rosa, M.S. National Institute on Drug Abuse crosa@nida.nih.gov |
 |
Michael A. Sesma, Ph.D. Chief Research Scientist Development Program Office for Special Populations National Institute of Mental Health msesma@mail.nih.gov |